Pacira | PCRX - Current Liabilities

Stock Price
24.51
Daily Change
-0.85 -3.35%
Monthly
4.34%
Yearly
-4.70%
Q2 Forecast
23.99

Pacira reported $120.59M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Assertio Holdings USD 166.78M 34.25M Sep/2025
Astellas Pharma JPY 1.32T 873M Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Cara Therapeutics USD 11.04M 362K Sep/2025
Coherus Biosciences USD 140.39M 231.91M Dec/2025
Heron Therapeutics USD 96.1M 6.39M Dec/2025
Ironwood Pharmaceuticals USD 242.5M 9.98M Sep/2025
J&J USD 57.72B 3.59B Mar/2026
Ligand Pharmaceuticals USD 37.45M 6.91M Dec/2025
Nektar Therapeutics USD 53.54M 12.8M Dec/2025
Novo Nordisk DKK 215.66B 18.7B Dec/2025
Omeros USD 85.5M 2.28M Jun/2025
Pacira USD 120.59M 13.51M Dec/2025
Perrigo USD 1.01B 132.4M Dec/2025
Pfizer USD 36.6B 1.13B Sep/2025
Supernus Pharmaceuticals USD 338.17M 7.54M Dec/2025
Teva Pharmaceutical Industries USD 13.46B 1.96B Dec/2025
Xeris Pharmaceuticals USD 109.57M 6.63M Dec/2025
Xoma USD 28.3M 6.81M Sep/2025
Zoetis USD 2.24B 428M Dec/2025